Trial
|
Studied treatment |
Control |
Patients |
Size |
Study type
|
Results |
NCT |
|
JCOG, 2005 | docetaxel | doxorubicin + cyclophosphamide | | NA | Exploratory | | |
TXT Group, 2002 | docetaxel | fluorouracil, vinorelbine | | NA | Exploratory | | |
304 Study Group, 1999 | docetaxel | mitomycin, vinblastine | | 392 (203/189) | Confirmatory - | | |
Sjostrom, 1999 | docetaxel | sequential methotrexate and 5-fluorouracil | | 282 (143/139) | Exploratory | | |
Bontenbal, 2005 | docetaxel + doxorubicin | fluorouracil, doxorubicin, cyclophosphamide | | NA | Confirmatory - | | |
Blohmer, 2010 | docetaxel + epirubicin | epirubicin, cyclophosphamide | | NA | Confirmatory - | | |
Bonneterre, 2004 | docetaxel + epirubicin | fluorouracil, epirubicin, cyclophosphamide | | NA | Confirmatory - | | |
HERNATA, 2011 | docetaxel + trastuzumab | vinorelbine, trastuzumab | | NA | Exploratory | | |
Rivera , 2008 | Weekly Docetaxel | Every three weeks Docetaxel | | NA | | | |
Tabernero , 2004 | Weekly Docetaxel | Every three weeks Docetaxel | | NA | | | |
Sedky , 2002 | Weekly Docetaxel | Every three weeks Docetaxel | | NA | | | |
Willemse , 2007 | Weekly Docetaxel | Every three weeks Docetaxel | | NA | | | |
Lung cancer (metastatic) - angiogenesis inhibitors in all type of patients - Taxanes in all type of patients |
TAX 320 100mg/m2, 2000 | docetaxel | | | 373 | | | |
TAX 317 (Shepherd) 100mg/m2, 2000 | docetaxel | | | NA | | | |
Esteban, 2003 | paclitaxel 80mg/m2 | m2docetaxel 36 mg/ | | 71 (36/35) | | | |
REVEL, 2014 | ramucirumab + docetaxel | docetaxel alone | | NA | | | NCT01168973 |
DISTAl 01 (Gridelli) , 2004 | weekly docetaxel | 3-weekly docetaxel | | 220 | | | |
Camps | weekly docetaxel | 3-weekly docetaxel | | NA | | | |
Schuette | weekly docetaxel | 3-weekly docetaxel | | NA | | | |
Gervais | weekly docetaxel | 3-weekly docetaxel | | NA | | | |
Lai | weekly docetaxel | 3-weekly docetaxel | | NA | | | |
Chen | weekly docetaxel | 3-weekly docetaxel | | NA | | | |